The distribution of the Organ-on-a-chip Market Share is highly concentrated among a few technology-pioneering companies and a growing number of specialized biotech startups. The competitive edge is currently defined less by manufacturing scale and more by intellectual property (IP) surrounding the microfluidic design, the ability to culture and maintain specialized cells (like primary...